We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 4 for:    autism and aquatic therapy
Previous Study | Return to List | Next Study

Aquatic Therapy and Autism Spectrum Disorders (AT&ASD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03195244
Recruitment Status : Completed
First Posted : June 22, 2017
Last Update Posted : April 21, 2022
Sponsor:
Information provided by (Responsible Party):
Sloan W. Rush, MD, Panhandle Eye Group, LLP

Brief Summary:
To compare the efficacy of one-on-one versus group-based aquatic therapy on the social interactions, behaviors and physical activities of children with autism spectrum disorders (ASDs).

Condition or disease Intervention/treatment Phase
Autism Spectrum Disorder Other: Aquatic Physical Therapy Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Aquatic Therapy and Autism Spectrum Disorders
Actual Study Start Date : June 12, 2017
Actual Primary Completion Date : April 12, 2022
Actual Study Completion Date : April 12, 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
No Intervention: Observation
Active Comparator: One-on-one Aquatic Therapy Other: Aquatic Physical Therapy
Swim Whisperer's Aquatic Therapy Sessions

Experimental: Group Aquatic Therapy Other: Aquatic Physical Therapy
Swim Whisperer's Aquatic Therapy Sessions




Primary Outcome Measures :
  1. Change in PedsQL Score [ Time Frame: Baseline and 10 weeks after intervention ]
    Survey



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   3 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Eligibility criteria:

  • DSM-V diagnosis of Autism Spectrum Disorder or DSM-IV diagnosis of Asperger's syndrome or high functioning atypical autism or pervasive development disorder - not otherwise specified or else the typical clinical findings and suspicion of an ASD
  • Treatment naïve to prior aquatic therapy

Exclusion criteria:

  • Not willing to undergo an investigational treatment
  • Unable to cooperate well enough to safely participate in aquatic therapy under the protocol guidelines
  • Known allergies to pool chemicals
  • Other significant co-morbidities which may include (but is not limited to): severe cerebral palsy with low motor function, advanced pulmonary disease, home oxygen requirement, spina bifida with low motor function, permanent feeding tubes, poorly controlled seizure disorder, chronic indwelling urinary catheters or any condition causing severe cognitive impairment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03195244


Locations
Layout table for location information
United States, Texas
Turn Center
Amarillo, Texas, United States, 79106
Sponsors and Collaborators
Sloan W. Rush, MD
Layout table for additonal information
Responsible Party: Sloan W. Rush, MD, MD, Panhandle Eye Group, LLP
ClinicalTrials.gov Identifier: NCT03195244    
Other Study ID Numbers: AT&ASD
First Posted: June 22, 2017    Key Record Dates
Last Update Posted: April 21, 2022
Last Verified: April 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Sloan W. Rush, MD, Panhandle Eye Group, LLP:
aquatic therapy, hydrotherapy
Additional relevant MeSH terms:
Layout table for MeSH terms
Autistic Disorder
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders